Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Guangzhou Xiangxue Pharmaceutical Co., Ltd. regards the development of traditional Chinese medicine and the modernization of traditional Chinese medicine as a long-term development strategy. Now, it has become a leading enterprise in the modernization of traditional Chinese medicine and a national high-tech enterprise with independent intellectual property rights, independent brands and independent innovation capabilities, focusing on the massive health industry in the fields of new traditional Chinese medicine decoction pieces, traditional Chinese patent medicines and simple preparations, functional health products, biomedical engineering, life science research, etc. Xiangxue has established over 60 subsidiaries in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan, and Ningxia, investing in the construction of large-scale GAP medicinal herb planting bases and GMP production bases, creating a complete industrial chain of traditional Chinese medicine resource development, new drug research and development, advanced manufacturing of traditional Chinese medicine, and modern logistics distribution, forming an integrated innovation of the entire industrial chain; Realizing the digitization of traditional Chinese medicine, including traceability, production and circulation, quality standards, safety evaluation, and efficacy evaluation, has become a new benchmark in the industry.
Headquarter Guangzhou
Establish Date 4/30/1986
Listed Code 300147.SZ
Listed Date 12/15/2010
Chairman Wang Yonghui.
CEO Wang Yonghui.
Website www.xphcn.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial